Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Jan O. Kemnade"'
Autor:
Ola Soliman, David C. Wilde, Jan O. Kemnade, Anita L. Sabichi, George Chen, Albert Chen, Samantha N. Little, Andrew T. Huang, David J. Hernandez, Vlad C. Sandulache
Publikováno v:
Laryngoscope Investigative Otolaryngology, Vol 8, Iss 4, Pp 895-902 (2023)
Abstract Objective Cisplatin forms the backbone of systemic chemotherapy treatment for oropharyngeal squamous cell carcinoma (OPSCC). The ideal cisplatin dosing regimen remains yet to be fully defined for achieving optimal efficacy and toxicity profi
Externí odkaz:
https://doaj.org/article/63e9ba405d214ea08428bffef1d69cc1
Autor:
Ratna Veeramachaneni, Wangjie Yu, Jared M Newton, Jan O Kemnade, Heath D Skinner, Andrew G Sikora, Vlad C Sandulache
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
Background Metformin is a commonly used antidiabetic medication which has demonstrated promise as an anticancer agent alone and in combination with conventional treatment regimens. There is increasing evidence that metformin can also generate immunom
Externí odkaz:
https://doaj.org/article/fa7f5b93207b47babfaf128e1c021790
Autor:
Marcus A. Florez, Jan O. Kemnade, Nan Chen, Wendy Du, Anita L. Sabichi, Daniel Y. Wang, Quillan Huang, Courtney N. Miller-Chism, Aparna Jotwani, Albert C. Chen, David Hernandez, Vlad C. Sandulache
Publikováno v:
Cancer Res Commun
We reviewed response to immune checkpoint inhibitors (ICI) of 207 patients with diagnoses of lung or head and neck cancer treated with chemotherapy/ICI combination therapy and ICI monotherapy between 2015 and 2020 at one of three clinical pavilions a
Autor:
David C. Wilde, Patricia D. Castro, Kaustav Bera, Syeling Lai, Anant Madabhushi, German Corredor, Can Koyuncu, James S. Lewis, Cheng Lu, Mitchell J. Frederick, Allan M. Frederick, Avery E. Haugen, Jose P. Zevallos, Erich M. Sturgis, Justin Shi, Andrew T. Huang, David J. Hernandez, Heath D. Skinner, Jan O. Kemnade, Wendong Yu, Andrew G. Sikora, Vlad C. Sandulache
Publikováno v:
Modern Pathology. 35:1045-1054
Oropharyngeal squamous cell carcinoma (OPSCC), largely fueled by the human papillomavirus (HPV), has a complex biological and immunologic phenotype. Although HPV/p16 status can be used to stratify OPSCC patients as a function of survival, it remains
Autor:
Vlad C. Sandulache, David Hernandez, Albert C. Chen, Aparna Jotwani, Courtney N. Miller-Chism, Quillan Huang, Daniel Y. Wang, Anita L. Sabichi, Wendy Du, Nan Chen, Jan O. Kemnade, Marcus A. Florez
Combined supplementary data file.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad9692a7ab17ef13e17bec4885e267b9
https://doi.org/10.1158/2767-9764.22545324.v1
https://doi.org/10.1158/2767-9764.22545324.v1
Autor:
Vlad C. Sandulache, David Hernandez, Albert C. Chen, Aparna Jotwani, Courtney N. Miller-Chism, Quillan Huang, Daniel Y. Wang, Anita L. Sabichi, Wendy Du, Nan Chen, Jan O. Kemnade, Marcus A. Florez
We reviewed response to immune checkpoint inhibitors (ICI) of 207 patients with diagnoses of lung or head and neck cancer treated with chemotherapy/ICI combination therapy and ICI monotherapy between 2015 and 2020 at one of three clinical pavilions a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d6c6c928ac0b7b8e0fb9c1aa441e78e
https://doi.org/10.1158/2767-9764.c.6550908
https://doi.org/10.1158/2767-9764.c.6550908
Autor:
Meenakshi Hegde, Patricia Castro, Wendong Yu, Vlad C. Sandulache, Andrew G. Sikora, Joshua Anil, Jan O. Kemnade, Masataka Suzuki, John Hicks, Emilie A K Warren
Publikováno v:
Head Neck
Background The purpose of this study is to describe human epidermal growth factor 2 (HER2) overexpression in head and neck squamous cell carcinoma (HNSCC) and re-evaluate its potential as a target for HER2-directed immunotherapies. Methods A retrospe
Autor:
Jared M. Newton, Jan O. Kemnade, Andrew G. Sikora, Ratna Veeramachaneni, Heath D. Skinner, Wangjie Yu, Vlad C. Sandulache
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
BackgroundMetformin is a commonly used antidiabetic medication which has demonstrated promise as an anticancer agent alone and in combination with conventional treatment regimens. There is increasing evidence that metformin can also generate immunomo
Autor:
Bahar Alam, Andrew T. Huang, Jan O. Kemnade, Vlad C. Sandulache, Albert C. Chen, David J. Hernandez
Publikováno v:
Am J Otolaryngol
PURPOSE: High-risk oropharyngeal squamous cell carcinoma (OPSCC) associated with tobacco exposure remains difficult to treat due to high rates of locoregional recurrence similar to oral cavity squamous cell carcinoma (OCSCC). Current NCCN guidelines
Publikováno v:
Cancer Research. 79:567-567
Background: Mutational neo-antigens (MuNeoAgs) are attractive targets for cancer vaccines because they are unique to tumors. However, limited epitope potential of point mutations, inherent difficulties predicting immunogenicity, and lack of shared mu